original ) (raw )Human papilloma virus vaccination: impact and recommendations across the world
Angela Bechini
Therapeutic Advances in Vaccines, 2014
View PDFchevron_right
Human papillomavirus vaccination uptake in Canada: A systematic review and meta-analysis
Razi Mahmood
International Journal of Preventive Medicine, 2017
View PDFchevron_right
Effectiveness of school-based and high-risk human papillomavirus vaccination programs against cervical dysplasia in Manitoba, Canada
Songul Bozat-Emre
International Journal of Cancer, 2019
View PDFchevron_right
Human Papillomavirus Vaccination: Expected Impacts and Unresolved Issues
Gary Freed
The Journal of Pediatrics, 2008
View PDFchevron_right
Ten years of anti-HPV vaccinations: what do we know?
Jan Kotarski
Menopausal Review, 2016
View PDFchevron_right
Prophylactic human papillomavirus vaccination update
Alison Fiander
The Obstetrician & Gynaecologist, 2009
View PDFchevron_right
Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
Martin Steinau
Journal of Infectious Diseases, 2013
View PDFchevron_right
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Suzanne Garland
Journal of Infectious Diseases, 2012
View PDFchevron_right
The Manitoba Human Papillomavirus vaccine surveillance and evaluation system
Brenda Elias
2010
View PDFchevron_right
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs
Norma Pérez
Vaccine, 2018
View PDFchevron_right
Prevalence and predictors of human papillomavirus vaccination in adolescent girls
Marie Bangura
Journal of the American Pharmacists Association, 2012
View PDFchevron_right
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States
Mary Barton
MMWR. Morbidity and mortality weekly report, 2014
View PDFchevron_right
Primary Care Physicians' Adherence to Guidelines and Their Likelihood to Prescribe the Human Papillomavirus Vaccine for 11- and 12-Year-Old Girls
Haiyan Qu
Women's Health Issues, 2016
View PDFchevron_right
Human papilloma virus vaccination: practical guidelines
Kaushal Yadav
International Journal of Research in Medical Sciences, 2014
View PDFchevron_right
Human papillomavirus vaccine uptake among 9- to 17-year-old girls
Zahava Berkowitz
Cancer, 2011
View PDFchevron_right
Cervical cancer: problem solved? Vaccinating girls against human papillomavirus
Emma Crosbie
BJOG: An International Journal of Obstetrics & Gynaecology, 2010
View PDFchevron_right
Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway
Ole Herman Ambur
The Journal of Infectious Diseases
View PDFchevron_right
Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008
Shan Taylor
Preventive Medicine, 2011
View PDFchevron_right
Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community
Darron Brown
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016
View PDFchevron_right
Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis
brenda kharono
Vaccines
View PDFchevron_right
Including males in Canadian human papillomavirus vaccination programs: a policy analysis
Gilla Shapiro
View PDFchevron_right
Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an ontario cohort of grade 8 girls
Linda Lévesque
BMC Public Health, 2011
View PDFchevron_right
Global human papilloma virus vaccine implementation: An update
Govindakarnavar Arunkumar
Journal of Obstetrics and Gynaecology Research, 2018
View PDFchevron_right
HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
F. Xavier Bosch
Gynecologic Oncology, 2009
View PDFchevron_right
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
Martin Steinau
The Journal of Infectious Diseases
View PDFchevron_right
American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
Francisco Garcia
CA: A Cancer Journal for Clinicians, 2007
View PDFchevron_right